News from NYU Langone Health
Live Science
An experimental drug compound could prevent and treat diabetes complications like poor wound healing and inflammation, regardless of blood sugar control, according to a new study in mice and human cells. Ann Marie Schmidt, MD, the Dr. Iven Young Professor of Endocrinology at NYU Grossman School of Medicine and director of the Diabetes Research Program at NYU Langone Health, co-authored the study. The drug works by blocking the interaction between two proteins, RAGE and DIAPH1, which drives harmful inflammation. Dr. Schmidt noted that while blood sugar control is key, it doesn't eliminate complication risks, underscoring the need for such therapies.
Also reporting was: , , ,
11/15/2025
WCBS-TV (New York, NY)
NYU Langone Health researchers announced significant progress in testing a human body's response to a pig kidney. Adam Griesemer, MD, associate professor of Surgery, and surgical director of Living Donor Liver Transplant Program and Pediatric Liver Transplant Program, explained that the team was able to successfully treat different forms of the body's rejection of the organ. Griesemer stated that this development is a crucial step forward. "This holds out hope that if we do see rejection in a living recipient, we'll be able to effectively treat it," he said.
11/14/2025
New York Post
Daniel J. Kaplan, MD, Assistant Professor, Department of Orthopedic Surgery at NYU Grossman, joins Brandon London for the weekly ‘Injury Report’ segment to break down Garrett Wilson’s outlook after the Jets’ star wide receiver was placed on injured reserve with a knee injury.
11/14/2025
New York Post
Jalen Brunson seems to have avoided the worst. He has a Grade 1 right ankle sprain, per a league source — the lowest severity possible. But what exactly does that actually entail, and what does that actually mean for Brunson’s outlook? “A typical ankle sprain is a range of stretching up to tearing of the ligaments on the outside of the ankle, that support the ankle from the lower leg to the foot,” commented Spencer Stein, MD, Clinical Assistant Professor, Department of Orthopedic Surgery at NYU Grossman.
11/14/2025
News Medical
Although midwives have long been associated with home births, roughly 90 percent of midwife-attended births in the U.S. now occur in hospitals. At NYU Langone Health, midwives are fully integrated into obstetric care, giving patients the benefits of personalized guidance in an environment equipped for urgent, advanced treatment. That approach shaped the experience of Juliette Sardou, who was referred to NYU Langone for further testing, where an evaluation by Colin K. Phoon, MD, a pediatric cardiologist in the Pediatric Congenital Heart Center at Hassenfeld Children's Hospital at NYU Langone, revealed a twisted (tortuous) ductus arteriosus - a heart condition that would require ongoing monitoring.
11/14/2025
WNYW-TV (New York, NY)
Michael Bogenschutz, MD, director of NYU Langone’s Center for Psychedelic Medicine, explained how psilocybin could help treat conditions like alcoholism and trauma. Describing brain scans of a patient under the influence of the substance, he noted a "massive increase in overall functional connectivity," where new connections are made that wouldn't occur in a normal state. Bogenschutz explained that this "brain rewiring" effect could help veterans reframe traumatic memories. He stated that in a clinical context, it allows patients "to experience their emotions, including their negative emotions and their traumatic memories, without becoming as easily overwhelmed."
11/15/2025
The New York Times
A University of Michigan survey of nearly 3,000 Americans aged 50 and older found that a minority identify as having a disability, despite many reporting functional difficulties. This reluctance means older adults often do not request accommodations they are legally entitled to in healthcare settings. Megan Morris, a rehabilitation researcher at NYU Langone Health and director of the Disability Equity Collaborative, commented that many people still feel that 'disability' is a dirty word, which may contribute to their hesitation in seeking help.
11/14/2025
CURE Magazine
Following the 2025 European Society of Medical Oncology Congress, Joshua Sabari, MD, assistant professor in the Department of Medicine at NYU Grossman School of Medicine and director of High Reliability Organization Initiatives at Perlmutter Cancer Center, discussed recent advances in prostate cancer care with Chandler Park, MD. Their conversation focused on the EMBARK trial, which Park described as a practice-changing study. The trial demonstrated a significant overall survival benefit for patients with biochemically recurrent prostate cancer treated with enzalutamide and leuprolide. Park noted this intermittent therapy approach is now a new standard of care for this patient population.
11/14/2025
Healio Cardiology
A study led by John A. Dodson, MD, MPH, director of NYU Langone's Geriatric Cardiology Program and an associate professor in the Department of Medicine's Leon H. Charney Division of Cardiology at NYU Langone Health, found a lottery-based financial incentive improved medication adherence for hypertension but did not significantly lower blood pressure. The BETTER-BP trial used behavioral economics to encourage patients at three New York City clinics to take their medication. While adherence improved to 71% in the lottery group versus 34% in the control group at six months, there was no significant difference in systolic blood pressure change, and adherence was not sustained after the lottery ended.
Also reporting was:
11/14/2025
Medscape
A new study found that myocardial infarction is associated with a twofold greater risk for late-onset epilepsy in patients over 60. In an accompanying editorial, Daniel Friedman, MD, neurologist at NYU Langone Comprehensive Epilepsy Center and director, Division of Epilepsy, Department of Neurology, and a co-author wrote that the findings support the hypothesis that covert cerebrovascular disease plays a role in some patients with late-onset epilepsy. They suggest that new-onset late-onset epilepsy should not be treated as an isolated entity but should raise concern for comorbid, undiagnosed atherosclerosis that requires optimal vascular risk factor control.
11/14/2025
Prevention
Experts debunk common myths about type 2 diabetes, including the beliefs that it is purely hereditary and that symptoms are always obvious. Priya Jaisinghani, MD, endocrinologist and obesity medicine specialist at NYU Langone Health, clinical assistant professor at NYU Grossman School of Medicine, notes that 8.7 million adults have undiagnosed diabetes. She explains that while some people with prediabetes may benefit from medication, others with type 2 diabetes might manage with lifestyle changes alone. Dr. Jaisinghani also states that new drugs have transformed diabetes management and warns that delaying necessary treatment can lead to serious complications.
Also reporting was:
11/14/2025
Conexiant
A large prospective study found that nearly 70% of patients with focal treatment-resistant epilepsy experienced substantial seizure reductions over time. The Human Epilepsy Project 2 study demonstrated a mean monthly seizure frequency reduction of nearly 69% among 126 participants. According to lead study author Ojas Potnis, MD, a resident in the Department of Neurology at the NYU Grossman School of Medicine, the findings imply that the condition improves over time. The study also noted that adding antiseizure drugs contributed to seizure reduction, and device-treated participants exhibited similar seizure trajectories to those without devices.
11/14/2025
Urology Times
Stacy Loeb, MD, professor in the Departments of Urology and Population Health at NYU Langone Health, shared key takeaways on the current state of prostate cancer screening. She highlighted the AUA's new recommendation for men to receive a baseline PSA test between ages 45 and 50. Loeb also discussed the shift toward risk-adapted screening tailored to individual profiles, including factors like ancestry and genetics. While guidelines align on shared decision-making, she noted differences in biopsy recommendations, with European guidelines now favoring the transperineal method.
11/14/2025
The Rheumatologist
At the ACR Convergence 2025 conference, experts discussed managing systemic lupus erythematosus (SLE) during pregnancy to optimize outcomes. Peter Izmirly, MD, professor in the Department of Medicine at NYU Grossman School of Medicine and co-director of NYU Lupus Clinic, explained that neonatal lupus syndrome is not true SLE in a child but is caused by maternal antibodies crossing the placenta. While symptoms like a rash can be temporary, congenital heart block is a serious complication. Dr. Izmirly also shared research indicating that hydroxychloroquine can reduce the risk of heart block in subsequent pregnancies for mothers with specific antibodies.
11/14/2025
The Dallas Express
Scientists are developing new treatments for autoimmune diseases that reprogram the immune system, with CAR-T therapy leading the research. The article highlights the story of Mileydy Gonzalez, a 35-year-old lupus patient who entered a CAR-T trial at NYU Langone Health. After struggling with the disease for over a decade, the treatment has left her pain- and medication-free, able to run and play with her son. The therapy, originally for blood cancers, is showing promise for lupus, myositis, and scleroderma, with researchers from other institutions also reporting successful results.
11/14/2025
KDFW-TV (Dallas, TX)
Chronic kidney disease has become the ninth leading cause of global death, according to a study by researchers at NYU Langone Health, the University of Glasgow, and the Institute for Health Metrics and Evaluation. The study found that cases rose to 788 million by 2023. Josef Coresh, M.D., Ph.D., the Terry and Mel Karmazin Professor of Population Health, Department of Population Health and director of NYU Langone’s Optimal Aging Institute, classified the condition as a major public health issue. Morgan Grams, M.D., Ph.D., the Susan and Morris Mark Professor of Medicine at the NYU Grossman School of Medicine and co-director of Division of Precision Medicine, noted the disease is underdiagnosed and undertreated, underscoring the need for more testing.
11/15/2025
SciTechDaily
A new study shows that natural hormonal shifts can alter how the brain handles rewards and learning. The research, a collaboration involving NYU Grossman School of Medicine’s Neuroscience Institute, found that estrogen boosts dopamine activity, which improves learning. According to senior author Christine Constantinople, PhD, professor in NYU Langone's Center for Neural Science, and lead author Carla Golden, an NYU postdoctoral fellow, the results offer a biological link between dopamine and learning. Suppressing estrogen reduced learning ability, indicating a possible connection to neuropsychiatric disorders. The work received support from NYU Langone Health.
11/15/2025
Archynetys
At the Infectious Diseases in Children Symposium, Adam J. Ratner, MD, MPH, director of pediatric infectious diseases at Hassenfeld Children’s Hospital at NYU Langone Health, discussed the 2025 measles outbreak, which has reached a 33-year high in the United States. He explained that measles is highly contagious but preventable through vaccination. Dr. Ratner provided pediatricians with guidance on diagnosing, treating, and preventing the disease, noting that 92% of the 1,723 cases this year occurred in unvaccinated or vaccination-unknown individuals. He also highlighted the seriousness of complications, including the fatal degenerative disease SSPE.
11/16/2025
Time.News
A new study by researchers at NYU Langone Health reveals that 58% of individuals using weight loss medications like Ozempic and Wegovy experience weight regain within one year of stopping treatment. The research, which analyzed data from 1.2 million American adults, found that patients regained an average of 7.5% of their weight after a full year without the medication. The findings underscore the importance of combining pharmaceutical treatments with long-term lifestyle interventions, such as diet and exercise, to achieve sustainable weight management and prevent weight recovery after treatment cessation.
11/15/2025
Today Headline
Potatoes are a nutrient-dense food with health benefits when prepared correctly, despite often having a negative reputation. Tal Kleiner, MBA, a clinical nutrition manager at NYU Langone Health, stated that while potatoes are often eaten as fries or chips, they are an 'amazing, nutrient-dense' food. The article notes that potatoes are a good source of vitamin C and phenolics, which can help protect against chronic diseases. Kleiner also explained that potatoes are complex carbohydrates that provide a steady source of energy and that certain varieties have a lower glycemic index.
11/15/2025
The Transmitter
The Society for Neuroscience has named Kevin B. Marvel as its next executive director, effective March 2026. The leadership change occurs as the organization confronts a funding crisis due to NIH budget cuts, declining membership, and reduced attendance at its annual meeting. Moses Chao, PhD, professor of cell biology, neuroscience and psychiatry at NYU Langone Health, and a former SfN president, commented on the situation, noting he expects this year's meeting attendance to fall below 20,000. He also suggested the organization could be more vocal about government policies affecting researchers.
11/16/2025
